Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

24 Mar 2017 07:00

RNS Number : 3655A
Standard Life Private Eqty Trst PLC
24 March 2017
Β 

Standard Life Private Equity Trust PLC

Β 

1. Investment update for the quarter ended 31 December 2016

Β 

Β· The Company's net asset value per ordinary share ("NAV") increased by 4.3% to 361.2p for the quarter ended 31 December 2016

Β· Realised gains and income during the quarter ended 31 December 2016 were Β£18.5 million (3.5% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were Β£9.7 million (1.8% of NAV); in addition, there were unrealised foreign exchange losses of Β£3.6 million (0.7% of NAV)

Β· 100.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2016

Β· Outstanding commitments were Β£312.5 million at 31 December 2016

Β· Liquid resources were Β£107.4 million at 31 December 2016

Β 

For the quarter ended 31 December 2016 the Company's NAV increased by 4.3% to 361.2p, from 346.4p at 30 September 2016. At 31 December 2016 the Company's net assets were Β£555.3 million (30 September 2016 - Β£532.6 million). NAV total return was 4.3% for the quarter from 1 October 2016 to 31 December 2016.

Β 

The closing value of the Company's portfolio of 50 private equity fund interests was Β£447.9 million at 31 December 2016 (30 September 2016 - Β£433.4 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 31 December 2016 were Β£6.1 million, comprising Β£9.7 million of unrealised gains on a constant exchange rate basis and Β£3.6 million of unrealised foreign exchange losses. The MSCI Europe Index and the FTSE All Share Index (both in sterling) rose by 4.4% and 3.1% respectively during the quarter. The unrealised foreign exchange losses were driven by the Euro depreciating by 1.4% relative to sterling over the quarter.

Β 

During the quarter ended 31 December 2016 the Company received Β£30.8 million of distributions (quarter ended 31 December 2015 - Β£45.1 million) and funded Β£20.3 million of draw downs (quarter ended 31 December 2015 - Β£17.0 million). The distributions received during the quarter generated Β£18.5 million of net realised gains and income, which was equivalent to a return of 2.5Β times the acquisition cost of the realised investments.

Β 

The Company made one new fund commitment of €34.0 million to the IK VIII Fund. The Company also agreed to acquire, through a secondary purchase, an original commitment of €20.0 million to Nordic Capital VII. The purchase price for the fund interest was €22.1 million, equivalent to a small premium of 2.0% to the most recent valuation date of 30 September 2016, adjusted for subsequent cashflows. The Company assumed outstanding commitments of Β£0.9 million on acquisition. The Company has existing commitments of €15.0 million and €30.0 million to Nordic Capital Fund VII and VIII respectively. This transaction completed on 12 January 2017.

Β 

The Company had total outstanding commitments to its 50 private equity fund interests of Β£312.5 million at 31 December 2016 (30 September 2016 - Β£305.9 million and 49 private equity fund interests). The Manager continues to believe that around Β£55 million of the Company's existing outstanding commitments are unlikely to be drawn.

Β 

At 31 December 2016 the Company had liquid resources of Β£107.4 million comprised of cash and cash equivalents (30 September 2016 - liquid resources of Β£105.9 million). The Company continues to have an undrawn Β£80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

Β 

Β 

2. Activity since 31 December 2016

Β 

On 27 January 2017 the Company paid a final dividend for the year ended 30 September 2016 of 3.6p per ordinary share (total for the year of 5.4p per ordinary share). The cost of the final dividend was Β£5.5 million.

Β 

During the period from 1 January to 10 March 2017 the Company received Β£21.8 million of distributions and funded Β£14.1 million of draw downs.

Β 

A new commitment of Β£22.0 million was also made to HgCapital 8 on 15 February.

Β 

At 10 March 2017 the Company had liquid resources of Β£91.5 million. The Company also had total outstanding commitments of Β£326.6 million.

Β 

The Company's estimated NAV at 28 February 2017 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2017 on or around 8 June 2017.

Β 

Β 

For further information please contact:-

Β 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

Β 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life plc.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTZXLFLDXFLBBD
Date   Source Headline
4th Dec 20177:00 amRNSAnnual Financial Report
30th Nov 20174:49 pmRNSDirectorate Change
14th Nov 20177:00 amRNSEstimated Net Asset Value at 31 October 2017
9th Nov 20174:50 pmRNSHolding(s) in Company
16th Oct 20174:14 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSEstimated Net Asset Value at 30 September 2017
3rd Oct 201712:37 pmRNSQuarterly Disclosure
20th Sep 20177:00 amRNSEstimated Net Asset Value at 31 August 2017
20th Sep 20177:00 amRNSQuarterly Trading Statement
13th Sep 20175:05 pmRNSDirector Declaration
25th Aug 20174:38 pmRNSDirector/PDMR Shareholding
17th Aug 20174:08 pmRNSHolding(s) in Company
14th Aug 20177:00 amRNSEstimated Net Asset Value at 31 July 2017
10th Aug 20174:08 pmRNSDirector/PDMR Shareholding
4th Aug 20171:54 pmRNSDirector/PDMR Shareholding
4th Aug 20171:53 pmRNSDirector/PDMR Shareholding
14th Jul 20177:00 amRNSEstimated Net Asset Value at 30 June 2017
4th Jul 201712:59 pmRNSQuarterly Disclosure
3rd Jul 20172:46 pmRNSUpdate research from QuotedData
14th Jun 20177:00 amRNSEstimated Net Asset Value at 31 May 2017
7th Jun 20171:48 pmRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSHalf-year Report
15th May 20177:00 amRNSEstimated Net Asset Value at 30 April 2017
8th May 20174:48 pmRNSHolding(s) in Company
2nd May 20171:09 pmRNSEdison update on Standard Life Private Eqty Trst
18th Apr 20177:00 amRNSEstimated Net Asset Value at 31 March 2017
4th Apr 201712:34 pmRNSQuarterly Disclosure
24th Mar 20177:00 amRNSEstimated Net Asset Value at 28 February 2017
24th Mar 20177:00 amRNSQuarterly Trading Statement
22nd Feb 201710:22 amRNSUpdate research from QuotedData
14th Feb 20177:00 amRNSEstimated Net Asset Value at 31 January 2017
7th Feb 20179:38 amRNSDirector/PDMR Shareholding
7th Feb 20179:37 amRNSDirector/PDMR Shareholding
31st Jan 20173:09 pmRNSChange of Name
24th Jan 20172:18 pmRNSResult of AGM
16th Jan 20177:00 amRNSEstimated Net Asset Value at 31 December 2016
4th Jan 20172:24 pmRNSQuarterly Disclosure
21st Dec 201612:33 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSChange of Broker
14th Dec 20167:00 amRNSEstimated Net Asset Value at 30 November 2016
5th Dec 201611:21 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSChange of Advisors
5th Dec 20167:00 amRNSEstimated Net Asset Value at 31 October 2016
5th Dec 20167:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSAnnual Financial Report
14th Nov 20167:00 amRNSEstimated Net Asset Values as at 31 October 2016
7th Nov 201611:04 amRNSEdison review: Standard Life Euro Priv Eqty Trst
14th Oct 20167:00 amRNSEstimated Net Asset Value as at 30 September 2016
10th Oct 20163:53 pmRNSDirector Declaration
6th Oct 201611:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.